Citation Impact
Citing Papers
The ASA Statement on p -Values: Context, Process, and Purpose
2016 Standout
Endogenous Testosterone and Mortality in Men: A Systematic Review and Meta-Analysis
2011 Standout
Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle‐aged men: a meta‐analysis
2005
Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome
2009
Testosterone Supplementation Therapy for Older Men: Potential Benefits and Risks
2003
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
2001 Standout
Testosterone Replacement and Resistance Exercise in HIV-Infected Men With Weight Loss and Low Testosterone Levels
2000
Skeletal muscle morphology in power-lifters with and without anabolic steroids
2005
Contradicted and Initially Stronger Effects in Highly Cited Clinical Research
2005
Preoperative Supraphysiological Testosterone in Older Men Undergoing Knee Replacement Surgery
2002
Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm
2010
Psychiatric side effects induced by supraphysiological doses of combinations of anabolic steroids correlate to the severity of abuse
2005
Effects of anabolic steroids on the muscle cells of strength-trained athletes
1999
Testosterone Therapy For Human Immunodeficiency Virus-Positive Men With and Without Hypogonadism
1999
Pharmacoepidemiology of anabolic androgenic steroids: a review
2004
Randomized placebo‐controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy
2001
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2010 Standout
Skeletal Muscle Fatigue: Cellular Mechanisms
2008 Standout
Short-Term Modulation of the Androgen Milieu Alters Pulsatile, But Not Exercise- or Growth Hormone (GH)-Releasing Hormone-Stimulated GH Secretion in Healthy Men: Impact of Gonadal Steroid and GH Secretory Changes on Metabolic Outcomes1
1997
Randomized Placebo-Controlled Trial of Androgen Effects on Muscle and Bone in Men Requiring Long-Term Systemic Glucocorticoid Treatment
2003
Anabolic Androgenic Steroids
2006 Standout
Why Most Published Research Findings Are False
2005 Standout
Anabolic steroid-induced hypogonadism – Towards a unified hypothesis of anabolic steroid action
2009
Muscular strength, body composition and health responses to the use of testosterone enanthate: a double blind study
1999
Novel nonsteroidal ligands with high binding affinity and potent functional activity for the androgen receptor
2002
Huntington's disease
2007 Standout
Effects of Supraphysiologic Doses of Testosterone on Mood and Aggression in Normal Men
2000
Use of doping agents, particularly anabolic steroids, in sports and society
2008 Standout
Abuse of anabolic androgenic steroids and related substances in sport and exercise
2004
Position Stand on Androgen and Human Growth Hormone Use
2009
Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis
2010 Standout
Testosterone-induced muscle hypertrophy is associated with an increase in satellite cell number in healthy, young men
2003
Anabolic Steroids
2002
Testosterone Replacement Increases Fat-Free Mass and Muscle Size in Hypogonadal Men1
1997
The adolescent brain and age-related behavioral manifestations
2000 Standout
Psychiatric and Neuropsychological Issues in Sports Medicine
2011
Emerging Issues in Androgen Replacement Therapy1
1997
Bioavailable Testosterone and Depressed Mood in Older Men: The Rancho Bernardo Study
1999
Painfully Obvious: A Longitudinal Examination of Medical Use and Misuse of Opioid Medication Among Adolescent Sports Participants
2013
Testosterone therapy in HIV wasting syndrome: systematic review and meta-analysis
2002
Long-term psychiatric and medical consequences of anabolic–androgenic steroid abuse: A looming public health concern?
2008
Chronic administration of the anabolic androgenic steroid nandrolone alters neurosteroid action at the sigma-1 receptor but not at the sigma-2 or NMDA receptors
2011
Violent crime and substance abuse: A medico-legal comparison between deceased users of anabolic androgenic steroids and abusers of illicit drugs
2007
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Psychiatric and hostility factors related to use of anabolic steroids in monozygotic twins
2006
Persistent primary hypogonadism associated with anabolic steroid abuse
2011
Effects of a supraphysiological dose of testosterone on physical function, muscle performance, mood, and fatigue in men with HIV-associated weight loss
2008
Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer
2004
Pharmacology of anabolic steroids
2008
Androgen regulation of satellite cell function
2005
Ultrastructural analysis of ruptured tendon from anabolic steroid users
1998
The Effects of Pharmacologically Induced Hypogonadism on Mood in HealthyMen
2004
Estrogen or Testosterone Increases Self-Reported Aggressive Behaviors in Hypogonadal Adolescents1
1997
The Mechanisms of Androgen Effects on Body Composition: Mesenchymal Pluripotent Cell as the Target of Androgen Action
2003
Therapeutic approaches for muscle wasting disorders
2006
Skeletal muscle dysfunction in critical care: Wasting, weakness, and rehabilitation strategies
2010
Psychosexual effects of three doses of testosterone cycling in normal men
1999
Anabolic–androgenic steroid dependence? Insights from animals and humans
2008
Toxicological findings and manner of death in autopsied users of anabolic androgenic steroids
2005
Psychological and Behavioural Effects of Endogenous Testosterone and Anabolic-Androgenic Steroids An Update
1996
Sex Differences of Endogenous Sex Hormones and Risk of Type 2 Diabetes
2006
Dose-Dependent Effects of Testosterone on Regional Adipose Tissue Distribution in Healthy Young Men
2004
Anabolic steroid users’ attitudes towards physicians
2004
Criminality Among Individuals Testing Positive for the Presence of Anabolic Androgenic Steroids
2006
ATHLETIC DRUG TESTING
1998
Simulated weightlessness-induced attenuation of testosterone production may be responsible for bone loss
1999
Construction and field validation of a self‐administered screener for testosterone deficiency (hypogonadism) in ageing men
2000
Techniques used in measuring human body composition
1998
Hindlimb Suspension and SPE-Like Radiation Impairs Clearance of Bacterial Infections
2014 StandoutNobel
Testosterone treatment improves body composition and sexual function in men with COPD, in a 6-month randomized controlled trial
2004
Sarcopenia
2019 Standout
Functional Disability 5 Years after Acute Respiratory Distress Syndrome
2011 Standout
Androgen deficiency in aging men: Role of testosterone replacement therapy
2000
Age Trends in the Level of Serum Testosterone and Other Hormones in Middle-Aged Men: Longitudinal Results from the Massachusetts Male Aging Study
2002 Standout
Difficulties in measuring the effect of testosterone replacement therapy on muscle function in older men
1999
Steroid Use and Long-Term Health Risks in Former Athletes
2002
The Effects of Varying Doses of T on Insulin Sensitivity, Plasma Lipids, Apolipoproteins, and C-Reactive Protein in Healthy Young Men
2002
Illicit anabolic–androgenic steroid use
2009
Selective androgen receptor modulators as function promoting therapies
2009
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Gender Differences in Resistance-Training-Induced Myofiber Hypertrophy Among Older Adults
2003
Sarcopenia: Its assessment, etiology, pathogenesis, consequences and future perspectives
2008
Anabolic Steroid Use in High School Students
2006
Androgens Stimulate Myogenic Differentiation and Inhibit Adipogenesis in C3H 10T1/2 Pluripotent Cells through an Androgen Receptor-Mediated Pathway
2003
The Neuroendocrinology of Stress: A Never Ending Story
2008 Standout
Testosterone Replacement Treatment Options for HIV-Infected Men
1997
Testosterone and Depression
2009
A trial of testosterone therapy for HIV-associated weight loss
1997
The Anabolic 500 Survey: Characteristics of Male Users versus Nonusers of Anabolic‐Androgenic Steroids for Strength Training
2011
Testosterone inhibits transforming growth factor-β signaling during myogenic differentiation and proliferation of mouse satellite cells: Potential role of follistatin in mediating testosterone action
2011
Doping and musculoskeletal system: short‐term and long‐lasting effects of doping agents
2010
The Use of a Sensitive Equilibrium Dialysis Method for the Measurement of Free Testosterone Levels in Healthy, Cycling Women and in Human Immunodeficiency Virus-Infected Women1
1998
Anabolic Steroids
2002
Sarcopenia: Current Concepts
2000
Managing the Risks of Prostate Disease During Testosterone Replacement Therapy in Older Men: Recommendations for a Standardized Monitoring Plan
2003
The Loss of Skeletal Muscle Strength, Mass, and Quality in Older Adults: The Health, Aging and Body Composition Study
2006 Standout
Anabolic-Androgenic Steroids
1995
The structural basis of bone fragility in men
1999
Androgen Receptor in Human Skeletal Muscle and Cultured Muscle Satellite Cells: Up-Regulation by Androgen Treatment
2004
Frailty in elderly people
2013 Standout
Oral Testosterone Supplementation Increases Muscle and Decreases Fat Mass in Healthy Elderly Males With Low-Normal Gonadal Status
2003 Standout
Drug Insight: testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging
2006
Drugs and Sport
1997
Pulmonary Rehabilitation
2007
Older Men Are as Responsive as Young Men to the Anabolic Effects of Graded Doses of Testosterone on the Skeletal Muscle
2005
Blood Testosterone Threshold for Androgen Deficiency Symptoms
2004
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Effects of Testosterone and Resistance Training in Men with Chronic Obstructive Pulmonary Disease
2004
Testosterone Supplementation in Older Men: A Rational Idea Whose Time Has Not Yet Come
2001
Measures of Aggression and Mood Changes in Male Weightlifters With and Without Androgenic Anabolic Steroid Use
2003
Gym and tonic: a profile of 100 male steroid users.
1997
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Current Concepts in Anabolic-Androgenic Steroids
2004
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment
2009 Standout
Anabolic Steroid Use by Male and Female Middle School Students
1998
Pulmonary rehabilitation for chronic obstructive pulmonary disease
2015 Standout
Testosterone Replacement in Older Hypogonadal Men: A 12-Month Randomized Controlled Trial
1997
Exercise and Physical Activity for Older Adults
2009 Standout
Serum Dihydrotestosterone and Testosterone Concentrations in Human Immunodeficiency Virus‐Infected Men With and Without Weight Loss
1999
Spinocerebellar ataxia type 6
1997
Testosterone Treatment and Mortality in Men with Low Testosterone Levels
2012 Standout
Human Body Composition: Advances in Models and Methods
1997
Testosterone and Frailty
1997
Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men: a randomized controlled trial.
1999
Interrelationships of serum testosterone and free testosterone index with FFM and strength in aging men
2002
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
The Endocrinology of Aging
1997 Science
Popular Ergogenic Drugs and Supplements in Young Athletes
2006
Testosterone Dose-Dependently Increases Maximal Voluntary Strength and Leg Power, but Does Not Affect Fatigability or Specific Tension
2003
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Differential Anabolic Effects of Testosterone and Amino Acid Feeding in Older Men
2003
Regulation of Myogenic Differentiation by Androgens: Cross Talk between Androgen Receptor/ β-Catenin and Follistatin/Transforming Growth Factor-β Signaling Pathways
2008
Advances in the Chemistry of Tetrahydroquinolines
2011 Standout
Measuring the Prevalence of Questionable Research Practices With Incentives for Truth Telling
2012 Standout
Genetic identification of HSD-1, a conserved steroidogenic enzyme that directs larval development inCaenorhabditis elegans
2008 StandoutNobel
Pharmacokinetics, Efficacy, and Safety of a Permeation-Enhanced Testosterone Transdermal System in Comparison with Bi-Weekly Injections of Testosterone Enanthate for the Treatment of Hypogonadal Men*
1999 Standout
Testosterone dose-response relationships in healthy young men
2001
Sex Steroids and the Construction and Conservation of the Adult Skeleton
2002
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
Effects of Testosterone Supplementation on Skeletal Muscle Fiber Hypertrophy and Satellite Cells in Community-Dwelling Older Men
2006
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
1999 Standout
Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy
2002 Standout
Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government
1997 Standout
Streptokinase in acute stroke
1998
Anabolic-Androgenic Steroid Therapy in the Treatment of Chronic Diseases
2001
From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis
2010 Standout
A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone
2010 Standout
Progressive resistance strength training for improving physical function in older adults
2009 Standout
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Satellite Cells and the Muscle Stem Cell Niche
2013 Standout
Effects of Testosterone Replacement with a Nongenital, Transdermal System, Androderm, in Human Immunodeficiency Virus-Infected Men with Low Testosterone Levels1
1998
Testosterone administration to older men improves muscle function: molecular and physiological mechanisms
2002
Role of IGF-I and IGF-binding proteins within diaphragm muscle in modulating the effects of nandrolone
2002
Effects of sex steroid hormones on regional fat depots as assessed by magnetic resonance imaging in transsexuals
1999
Discovery of a Potent, Orally Active, Nonsteroidal Androgen Receptor Agonist: 4-Ethyl-1,2,3,4-tetrahydro-6- (trifluoromethyl)-8-pyridono[5,6-g]- quinoline (LG121071)
1999
Anabolic-Androgenic Steroid Use in the United States
1993 Standout
Sarcopenia: European consensus on definition and diagnosis
2010 Standout
Testosterone Replacement in Older Hypogonadal Men: A 12-Month Randomized Controlled Trial
1997
Testosterone injection stimulates net protein synthesis but not tissue amino acid transport
1998
Anabolic-Androgenic Steroid Therapy in the Treatment of Chronic Diseases
2001
The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trial
2011
The Impact of Recanalization on Ischemic Stroke Outcome
2007 Standout
Ergogenic Aids: A Review of Basic Science, Performance, Side Effects, and Status in Sports
2004
Free Radicals in the Physiological Control of Cell Function
2002 Standout
Elevated Testosterone Induces Apoptosis in Neuronal Cells
2006
Advances in Male Contraception
2008
Combined administration of testosterone plus an ornithine decarboxylase inhibitor as a selective prostate‐sparing anabolic therapy
2013
Works of Ray Tricker being referenced
The effects of supraphysiological doses of testosterone on angry behavior in healthy eugonadal men--a clinical research center study.
1996
The Effects of Supraphysiologic Doses of Testosterone on Muscle Size and Strength in Normal Men
1996
The Incidence of Anabolic Steroid Use among Competitive Bodybuilders
1989
Issues Related to Drug Abuse in College Athletics: Athletes at Risk
1989
Painkilling Drugs in Collegiate Athletics: Knowledge, Attitudes, and Use of Student Athletes
2000